378 related articles for article (PubMed ID: 10334384)
1. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
2. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
3. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
5. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
Schuler M; Tretter T; Schneller F; Huber C; Peschel C
Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
[TBL] [Abstract][Full Text] [Related]
6. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the 'CD40 system'.
Planken EV; Dijkstra NH; Willemze R; Kluin-Nelemans JC
Leukemia; 1996 Mar; 10(3):488-93. PubMed ID: 8642867
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
8. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
Nerl C; Janssen O; Kabelitz D
Leukemia; 1988 Dec; 2(12 Suppl):50S-56S. PubMed ID: 3059076
[TBL] [Abstract][Full Text] [Related]
9. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
10. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
[TBL] [Abstract][Full Text] [Related]
12. Production of tumor necrosis factor-alpha by normal and malignant B lymphocytes in response to interferon-alpha, interferon-gamma and interleukin-4.
Jansen JH; Wientjens GJ; Willemze R; Kluin-Nelemans JC
Leukemia; 1992 Feb; 6(2):116-9. PubMed ID: 1552742
[TBL] [Abstract][Full Text] [Related]
13. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
Decker T; Schneller F; Kronschnabl M; Dechow T; Lipford GB; Wagner H; Peschel C
Exp Hematol; 2000 May; 28(5):558-68. PubMed ID: 10812246
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy?
Bezares F; Kohan S; Sacerdote de Lustig E; Farías E; Murro H; Horisberger MA
J Interferon Cytokine Res; 1996 Jul; 16(7):501-5. PubMed ID: 8836914
[TBL] [Abstract][Full Text] [Related]
16. Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders.
Heslop HE; Bianchi AC; Cordingley FT; Turner M; Chandima W; De Mel CP; Hoffbrand AV; Brenner MK
J Exp Med; 1990 Dec; 172(6):1729-34. PubMed ID: 2258703
[TBL] [Abstract][Full Text] [Related]
17. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
18. CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
Kater AP; Evers LM; Remmerswaal EB; Jaspers A; Oosterwijk MF; van Lier RA; van Oers MH; Eldering E
Br J Haematol; 2004 Nov; 127(4):404-15. PubMed ID: 15521917
[TBL] [Abstract][Full Text] [Related]
19. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
20. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Crawford DH; Catovsky D
Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
